Comparisons between patients who had favorable and unfavorable outcomes 3 months after recanalization
Patient Demographics | % or Median (IQR) | P | |
---|---|---|---|
Favorable Outcome (n = 22) | Unfavorable Outcome (n = 13) | ||
Age (yr) | 64 (61–69) | 73 (65–77) | .040 |
Male | 90.9 | 84.6 | .618 |
Medical history | – | – | – |
Diabetes mellitus | 22.7 | 15.4 | .689 |
Hypertension | 54.5 | 53.8 | 1.000 |
Hypercholesterolemia | 27.3 | 30.8 | 1.000 |
Smoking | 45.5 | 53.8 | .733 |
Cardiac disease | 18.2 | 7.7 | .630 |
Prior stroke | 9.1 | 30.8 | .166 |
Preprocedural findings | |||
Time to hospital (min)a | 180 (138–208) | 180 (100–210) | .851 |
Time to IA therapy (min)a | 255 (200–279) | 280 (180–360) | .669 |
NIHSS score at admission | 9 (8–14) | 17 (13–18) | .003 |
Modified Rankin Scale score | 4 (3–4) | 4 (4–4) | .005 |
3 | 45.5 | 7.7 | .027 |
4 | 54.5 | 69.2 | .486 |
5 | 0.0 | 23.1 | .044 |
Right-sided occlusion | 27.3 | 69.2 | .032 |
Tandem occlusion site | – | – | .247b |
M1 | 63.6 | 84.6 | .259 |
M2 | 22.7 | 0.0 | .134 |
Distal ICA thrombus | 13.6 | 15.4 | 1.000 |
Received IV rtPA | 18.2 | 30.8 | .433 |
Periprocedural findings | |||
Procedure duration (min) | 90 (66–128) | 95 (70–110) | .891 |
Urokinase dose (×104 U) | 10 (10–30) | 20 (10–20) | .648 |
TICI grade | – | – | .006c |
IIa | 9.1 | 53.8 | .006 |
IIb | 22.7 | 15.4 | .689 |
III | 68.2 | 30.8 | .043 |
Complications | 0.0 | 15.4 | .144 |
Symptomatic hemorrhage | 0.0 | 7.7 | .371 |
Brain swelling | 0.0 | 7.7 | .371 |
Follow-up evaluation at 3 months | |||
NIHSS scored | 2 (2–4) | 9 (6–16) | <.001 |